Business Wire

First Enterprise Quantum Computer Purchase in Japan: IQM to Deploy System to TOYO Corporation

27.4.2026 08:00:00 CEST | Business Wire | Press release

Share

First enterprise quantum computer purchase in Japan cements IQM's position as the global leader in deployed quantum computers The Radiance 20-qubit system will enable TOYO to explore various industry use cases, while advancing a hybrid quantum-HPC infrastructure. This will be the third quantum computer to be deployed by IQM in the Asia-Pacific region.

IQM Quantum Computers, the global leader in superconducting quantum computers, today announced the purchase of its full-stack 20-qubit quantum computer by TOYO Corporation, marking the first enterprise quantum system deployment in Japan.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260426053944/en/

(From Left): Toshiya Kohno, Representative Director, President and CEO of TOYO Corporation, and Jan Goetz, CEO & Co-founder of IQM Quantum Computers.

The Radiance 20-qubit system will be made available in both on-premises and cloud environments and will be delivered by the end of 2026. The deployment expands IQM's installed base across the Asia-Pacific region, where the company already has deployed systems in South Korea and Taiwan.

TOYO will operate the quantum computer to support Japanese enterprises and researchers in developing quantum use cases, while integrating the system with high-performance computing (HPC) infrastructure and building the technical workforce Japan's quantum strategy demands.

Japan has one of the largest publicly funded national quantum programs. The country has set some of the most ambitious national quantum targets of any country — 10 million domestic users of quantum technologies and 50 trillion yen in quantum-generated production value by 2030. Meeting those targets requires more than research programs. It requires institutions that own, operate, and grow with real quantum hardware.

Commenting on the deployment, Jan Goetz, CEO and Co-founder of IQM Quantum Computers, said: "Leading enterprises are building real quantum capabilities by owning the infrastructure, operating it, and growing with it. TOYO's commitment to this approach represents an important step in realizing Japan´s national quantum strategy based on IQM´s leading quantum computing technology."

Toshiya Kohno, Representative Director, President and CEO, TOYO Corporation, said:“Quantum technology is an essential strategic field for future economic growth, especially for the new era of Japanese manufacturing. The competition for practical implementation—such as integration with HPC, use-case development, and business talent development—has already begun, moving beyond theory and research. With the cooperation of IQM, we will promote the social implementation of quantum technologies in Japan ahead of the world.”

About IQM Quantum Computers:

IQM Quantum Computers is a global leader in superconducting quantum computers, delivering full-stack quantum systems and cloud platform access to research institutions, universities, high-performance computing centers, and national laboratories worldwide. IQM's on-premises deployment model gives customers direct ownership and control of their quantum infrastructure. Founded in 2018, headquartered in Finland, it has over 350 employees. IQM operates across Europe, Asia, and North America. IQM has announced its plans to become the first publicly listed European quantum company on a major U.S. stock exchange by merging with Real Asset Acquisition Corp. (Nasdaq: RAAQ); with a dual listing on the Helsinki Stock Exchange also under consideration.

About TOYO Corporation:

TOYO Corporation (Head Office: Tokyo, Japan) contributes to technological innovations as a leading provider of advanced measurement solutions. Through its variety of business segments - Sustainable Energy, Advanced Mobility, ICT (Information and Communication Technologies) and Information Security, EMC (Electromagnetic Compatibility) and Antenna Systems, Defense and Security, Ocean, Software Quality and Productivity, Life Science, and Quantum Solutions, the company is focused on providing solutions to emerging markets such as clean energy and autonomous vehicle development. TOYO also makes significant R&D investments to develop in-house technologies and products, and its growth strategies include investing in new business, conducting M&A, and developing its market presence in global markets. By making available the most advanced market-based solutions, TOYO is at the forefront of helping to shape a safe and environmentally-friendly society and develop industries.

View source version on businesswire.com: https://www.businesswire.com/news/home/20260426053944/en/

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

Riskified Study Finds Consumers Aren’t Ready to Hand Over Control as AI Transforms Shopping, with Over Half Afraid of Online Fraud27.4.2026 14:00:00 CEST | Press release

New Q1 2026 “Agentic Commerce Pulse” survey from Riskified reveals a growing trust gap in agent-driven commerce, as consumers embrace AI across the shopping journey but remain hesitant to hand over control amid concerns over fraud, security, and accountability Riskified (NYSE: RSKD), a global leader in ecommerce fraud and risk intelligence, today released the Q1 2026 edition of its Agentic Commerce Pulse, a quarterly research series tracking agentic commerce risks and consumer engagement. Following Riskified’s inaugural Q4 2025 survey, which first highlighted the rapid emergence of agent-driven commerce, the latest findings reveal a more complex reality: while AI adoption remains strong, consumer trust is not keeping pace. A widening gap is emerging between how shoppers use AI and how much control they are willing to give it. The survey, conducted among consumers across the United States and the United Kingdom, shows that AI is now firmly embedded in product discovery and decision-maki

Nine in 10 Expect Cross-Border M&A Surge, But 71% of Dealmakers Have Already Changed Course on Deals27.4.2026 14:00:00 CEST | Press release

90% of dealmakers expect cross-border M&A activity to increase over the next 12–24 months75% cite foreign direct investment screening as the biggest threat to deal completion88% report longer signing-to-close timelines than three years ago Cross-border M&A is set for a strong resurgence, with nine in 10 senior dealmakers expecting activity to increase over the next 12 to 24 months, according to new research from CSC, the leading provider of business administration and compliance solutions. However, despite this renewed momentum, execution risk is rising, with regulatory scrutiny and operational challenges making it harder to get deals over the line. CSC¹ surveyed 200 director level and above global dealmakers across private equity, corporate, legal, and advisory roles who have worked on cross-border transactions in the past two years. The report, The New Reality of Cross-Border M&A: More Deals, More Friction, explores how firms are navigating an increasingly complex global deal environ

Mundipharma announces positive topline results from Phase III ReSPECT trial assessing ▼REZZAYO® (rezafungin) for the prophylaxis of invasive fungal diseases in allogeneic haematopoietic stem cell transplantation patients27.4.2026 13:43:00 CEST | Press release

For Trade and Medical Media Only The study primary endpoint was met, showing non-inferiority vs. standard antimicrobial regimen in fungal-free survival at Day 90 Study showed favourable benefit for toxicity-related discontinuations and drug-drug interactions (DDIs) Rezafungin was well tolerated, with a safety profile comparable to standard antimicrobial regimens (SARs) Mundipharma today announced positive Phase III topline results from the global ReSPECT clinical trial evaluating REZZAYO® (rezafungin acetate) for prophylaxis of invasive fungal diseases (IFDs) in adult patients undergoing allogeneic haematopoietic stem cell transplantation (HSCT). The ReSPECT Phase III trial, one of the largest antifungal, multicentre, randomised, double-blind studies evaluated the efficacy and safety of once weekly rezafungin compared with a SAR for the prophylaxis of IFDs, including infections caused by Candida, Aspergillus, and Pneumocystis, in adults undergoing allogeneic HSCT. Patients undergoing a

vVARDIS Announces Investment from Apollo—Achieves Unicorn Status27.4.2026 13:00:00 CEST | Press release

Investment will support global commercial expansion of the Curodont™ technology platform, the first and only non-invasive peptide-containing formulations designed to treat tooth decay drill-free throughout the depth of the lesion vVARDIS Holding AG (“vVARDIS”), a high-growth dental medtech company pioneering non-invasive cavity treatment, today announced a strategic minority investment from Apollo-managed funds (“Apollo Funds”). The investment will support vVARDIS’ next phase of global growth and commercial expansion, including the continued rollout of its Curodont™ suite of products. The investment establishes vVARDIS as one of Europe’s few privately owned, billion-dollar-plus, healthcare companies. vVARDIS’ founders and co-CEOs, Drs. Haley and Goly Abivardi, will retain a substantial majority shareholding in the company. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260415938477/en/ Photo credit: Jos Schmid, Photographer

tesa Selects Kinaxis as the Digital Backbone for Global Integrated Business Planning Transformation27.4.2026 13:00:00 CEST | Press release

Kinaxis Maestro™ platform to serve as the foundation for a multi‑year transformation to resilient, globally orchestrated planning ecosystem Kinaxis® (TSX: KXS), a global leader in end‑to‑end supply chain orchestration, today announced that tesa SE, a global manufacturer of adhesive tapes and self-adhesive product solutions, has selected the Kinaxis Maestro™ platform as a core enabler of its global, multi‑year supply chain and integrated business planning (IBP) transformation. Following an extensive evaluation, tesa selected Kinaxis to support its evolution from regionally fragmented planning practices toward a centrally governed, globally orchestrated IBP operatingmodel. Kinaxis will support tesa in improving enterprise-wide transparency, strengthening resilience, and enabling faster, more informed decision making across an increasingly complex and volatile global supply chain network. With 130 years of innovation, tesa is one of the world’s leading manufacturers of adhesive tapes and

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye